Trial intelligence / Profile preview

Whole Brain Irradiation in PCNSL After High-dose Methotrexate

NCT00153530Phase 4Completed

Sponsor
Charité – Universitätsmedizin Berlin
Start
May 2000
Modality
Orthosteric Ligands
Countries
1
01

Overview

A Phase 4 trial of methotrexate in primary central nervous system lymphoma (PCNSL), sponsored by Charité – Universitätsmedizin Berlin. Started May 2000; status: completed.

02

Drugs

methotrexate
03

Conditions

primary central nervous system lymphoma (PCNSL)

Beyond the preview

Go deeper on NCT00153530.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00153530.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call